FDA Adverse Event Malfunction Summary report: N

VITROS CHEMISTRY PRODUCTS VALP REAGENT

MDR report key: 2746009 · Received September 14, 2012

Report

Report Number
1319808-2012-00026
Event Type
Malfunction
Date Received
September 14, 2012
Date of Event
August 13, 2012
Report Date
September 14, 2012
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
LEG
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION CONFIRMED THAT HIGHER THAN EXPECTED VITROS VALP PATIENT AND QUALITY CONTROL RESULTS WERE OBTAINED AFTER UNRELATED SERVICE ACTIONS WHILE USING THE VITROS 5,1 FS CHEMISTRY SYSTEM. THE INVESTIGATION DETERMINED THAT THE VITROS 5,1 FS CHEMISTRY SYSTEM WAS PERFORMING AS EXPECTED AT THE TIME OF THE EVENT. THE CAUSE FOR THE EVENT HAS NOT BEEN DETERMINED, AND THE INVESTIGATION IS ONGOING. VITROS VALP LOT 2511-17-1994, AN INSTRUMENT ISSUE RELATED TO THE SERVICE ACTIONS PERFORMED, AND THE BIORAD CONTROL FLUIDS IN USE HAVE NOT BEEN RULED OUT AS POTENTIAL CONTRIBUTING FACTORS.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED HIGHER THAN EXPECTED VITROS VALP PATIENT AND QUALITY CONTROL RESULTS (VALP PATIENT RESULTS=72.30, 39.33, 69.32 G/ML VS. AN EXPECTED RESULT= 58.07, 27.09, 53.36 G/ML RESPECTIVELY AND VALP QUALITY CONTROL BIORAD L2 RESULT= 178.15 G/ML VS. AN EXPECTED RESULT= 148.00 G/ML) WHILE USING THE VITROS 5,1 FS CHEMISTRY SYSTEM. BIASED RESULTS OF THE DIRECTION AND MAGNITUDE OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THE EVENT WERE TO OCCUR WITH PATIENT SAMPLES. THE HIGHER THAN EXPECTED VITROS VALP PATIENT RESULTS WERE NOT REPORTED OUT OF THE LABORATORY. THERE WAS NO ALLEGATION OF PATIENT HARM AS A RESULT OF THIS EVENT. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITROS CHEMISTRY PRODUCTS VALP REAGENT IN-VITRO DIAGNOSTIC LEG ORTHO-CLINICAL DIAGNOSTICS 2511-17-1994

Patients

Seq Age Sex Outcome Treatment
1